Cargando…
732. Evaulation of Micafungin Treatment at Pediatric Patients: A cross-sectional Study from Tertiary Pediatric Centre
BACKGROUND: Micafungin is one of three currently available echinocandin for treatment of candidiasis and candidemia. METHODS: Children who were treated for micafungin for possible or proven invasive Candidia infection between May 2017 and October 2019 were included. RESULTS: In this cross-sectional...
Autores principales: | Arıkan, Kamile, Bayram, Nuri, devrim, İlker, Akaslan-Kara, Ayküke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777664/ http://dx.doi.org/10.1093/ofid/ofaa439.924 |
Ejemplares similares
-
Can Hematological Findings of COVID-19 in Pediatric Patients Guide Physicians Regarding Clinical Severity?
por: Ötiken Arıkan, Kamile, et al.
Publicado: (2021) -
Micafungin for the treatment of pediatric invasive fungal infections
por: Arrieta, A, et al.
Publicado: (2009) -
Evaluation of proximal tubule functions in children with COVID-19: a prospective analytical study
por: Devrim, Fatma, et al.
Publicado: (2022) -
Readmission reasons of pediatric patients diagnosed with multisystem inflammatory syndrome after discharge
por: Cem, Ela, et al.
Publicado: (2022) -
Estimating risk factors for acinetobacter bacteremia in pediatric settings
por: Ekinci, Faruk, et al.
Publicado: (2013)